Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: * alive patients who attended the solidarity finland remdesivir sub-study eligibility criteria for solidarity finland remdesivir -study: inclusion criteria: * adult patients, 18 years and older * laboratory-confirmed sars-cov-2 infection * admitted to the hospital ward or the intensive care unit (icu) * patient provides written informed consent prior to initiation of the study or close relative/legal representative provides written informed consent prior to initiation of the study according to the presumed will of the patient when patient is unable to give consent. * no anticipated transfer within 72 hours to a non-study hospital

inclusion criteria: * alive patients who attended the solidarity finland remdesivir sub-study eligibility criteria for solidarity finland remdesivir -study: inclusion criteria: * adult patients, 18 years and older * laboratory-confirmed sars-cov-2 infection * admitted to the hospital ward or the intensive care unit (icu) * patient provides written informed consent prior to initiation of the study or close relative/legal representative provides written informed consent prior to initiation of the study according to the presumed will of the patient when patient is unable to give consent. * no anticipated transfer within 72 hours to a non-study hospital

July 28, 2021, noon usa

inclusion criteria: - alive patients who attended the solidarity finland remdesivir sub-study eligibility criteria for solidarity finland remdesivir -study: inclusion criteria: - adult patients, 18 years and older - laboratory-confirmed sars-cov-2 infection - admitted to the hospital ward or the intensive care unit (icu) - patient provides written informed consent prior to initiation of the study or close relative/legal representative provides written informed consent prior to initiation of the study according to the presumed will of the patient when patient is unable to give consent. - no anticipated transfer within 72 hours to a non-study hospital

inclusion criteria: - alive patients who attended the solidarity finland remdesivir sub-study eligibility criteria for solidarity finland remdesivir -study: inclusion criteria: - adult patients, 18 years and older - laboratory-confirmed sars-cov-2 infection - admitted to the hospital ward or the intensive care unit (icu) - patient provides written informed consent prior to initiation of the study or close relative/legal representative provides written informed consent prior to initiation of the study according to the presumed will of the patient when patient is unable to give consent. - no anticipated transfer within 72 hours to a non-study hospital